Clinical Features of Variant Creutzfeldt-Jakob Disease
The possibility that a new form of human prion disease, variant Creutzfeldt-Jakob disease (vCJD) had occurred in the UK was first raised by the identification of a small number of cases with unusual clinical characteristics. Atypical features included a young age at death, a predominantly psychiatric presentation, a relatively extended duration of illness and the absence of the ‘typical’ periodic electroencephalogram seen in sporadic CJD. Diagnostic criteria for vCJD have now been formulated and partially validated. Magnetic resonance imaging of the brain shows high signal in the posterior thalamus in the great majority of cases and all tested cases to date have been methionine homozygous at codon 129 of the prion protein gene (PRNP). There is a need to try and improve early diagnosis, particularly if effective treatments are developed.
KeywordsPrion Protein Bovine Spongiform Encephalopathy Neurological Feature Human Prion Disease Prion Protein Gene
Unable to display preview. Download preview PDF.
- Green AJE, Thompson EJ, Stewart GE, Zeidler M, Mackenzie JM, Macleod MA, Iron–side JW, Will RG, Knight RSG (2001) Use of 14–3–3 and other brain–specific proteins in CSF in the diagnosis of variant Creutzfeldt–Jakob disease. JNNP 2001: 744 – 748Google Scholar
- Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A, Al-Sarraj S, Ironside JW, Lantos PL, Collinge J (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353: 183–184PubMedCrossRefGoogle Scholar
- McNaughton HK, Will RG (1997) Creutzfeldt-Jakob disease presenting acutely as stroke: an analysis of 30 cases. Neurological Infections and Epidemiology 2: 19–24Google Scholar
- Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224–233PubMedCrossRefGoogle Scholar
- Zerr I, Pocchiari M, Collins S, Brandel J–P, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie–Laupretre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremon A, Budka H, Laplanche J–L, Will RG, Poser S (2000) Analysis of EEG and CSF 14–3–3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology 55 (6): 811 – 815PubMedCrossRefGoogle Scholar